Cat. No. | Product name | CAS No. |
DCC5550 |
XAX-162
Quantity (mg or Unit) Unit Price ($/mg or $/Unit) Final Price 100 $26.55 Total: $2,655.00 50 $30.68 Total: $1,534.00 25 $35.99 Total: $899.75 10 $42.48 Total: $424.80 5 $50.15 Total: $250.75 |
|
DCC5551 |
xc-409
Novel PKM2 activator |
931066-63-6 |
DCC5552 |
Xen103
Potent and Selective Stearoyl-CoA Desaturase-1 Inhibitor |
840489-44-3 |
DCC5553 |
Xie18-6
Novel INK4C inhibitor, specifically blocking the bioactivity of p18 protein and promoting human and murine hematopoietic stem cell ex vivo expansion |
1286862-52-9 |
DCC5554 |
Xist Ligand X1
Novel non-coding RNA prototype Xist ligand, specifically binding the RepA motif of Xist, reducing the conformational space of RepA, displacing cognate interacting protein factors (PRC2 and SPEN), suppressing histone H3K27 trimethylation, and blocking init |
|
DCC5555 |
Xl-13n
Novel dual inhibitor of AF9 and ENL YEATS domains |
|
DCC5556 |
Xl-147
Novel Potent Pan-Filovirus Inhibitor, showing potent inhibition against infectious EBOV Zaire (0.09 μM) and MARV (0.64 μM) |
|
DCC5557 |
Xl-418
Novel Akt1/2 inhibitor |
1056474-52-2 |
DCC5558 |
Xr9051 Hydrochloride
Potent modulator of P-glycoprotein-mediated multidrug resistance (MDR), inhibiting the binding of cytotoxics to P-glycoprotein |
180422-22-4 |
DCC5559 |
Xstax-vhll
Novel selective β-catenin degrader |
|
DCC5560 |
Xylariamide A
Carbonic anhydrase inhibitor; Fungal metabolite |
853259-88-8 |
DCC5561 |
Xylarianaphthol-1
Novel activator of p21 promoter in a p53-independent manner |
1620084-30-1 |
DCC5562 |
Y08624
Novel TRIM24/BRPF1 dual inhibitor with IC 50 values of 0.98 and 1.16 μM, respectively |
|
DCC5563 |
Y2 Antagonist 36
Novel non-peptidic highly potent, soluble and selective NPY Y2 antagonist |
1185845-15-1 |
DCC5564 |
Y2-antagonist-2
Novel, selective, soluble non-peptidic NPY Y2 receptor antagonist with enhanced CNS exposure |
1262495-12-4 |
DCC5565 |
Y-39983 Dihydrochloride
Selective Rho-associated kinase (ROCK) inhibitor |
173897-44-4 |
DCC5566 |
Yak037
Tamoxifen-analog that Suppresses Glial L-Glutamate Transport Activity without Interaction with Estrogen_receptor>Estrogen Receptors |
1177261-99-2 |
DCC5567 |
Ycw-e11
Novel Inhibitor of Antiapoptotic Bcl-2 Family Proteins |
1519043-97-0 |
DCC5568 |
Yh18968
Novel GPR119 Agonist, improving glucose tolerance and augmenting the glucose lowering effect as well as the plasma level of active GLP-1 in normal mice in combination treatment with a dipeptidyl peptidase 4 (DPP-4) inhibitor |
1632498-56-6 |
DCC5569 |
Yh-gka
Novel glucokinase activator, significantlt decreasing in blood glucose levels with no adverse effects on serum lipids or body weight |
|
DCC5570 |
Yk-5-252
Novel dual action combretastatin A-4 (CA-4) prodrug, releasing CA-4 through a disulfide bond cleavage mechanism and containing a near-infrared (NIR) fluorophore |
|
DCC5571 |
Ykl-05-093
Novel salt inducible kinase (SIK) inhibitor, increasing bone formation and bone mass |
2172616-44-1 |